Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Oxandrolone and Proviron Interaction: Avoid | Peptide Database

Compound Profiles Oxandrolone Oral Anabolic Steroid | Lean Mass & Recovery Oxandrolone exerts its anabolic effects primarily through binding to the intracellular androgen receptor (AR), promoting nitrogen retention and protein synthesis in skeletal muscle tiss

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Oxandrolone

Oral Anabolic Steroid | Lean Mass & Recovery

Oxandrolone exerts its anabolic effects primarily through binding to the intracellular androgen receptor (AR), promoting nitrogen retention and protein synthesis in skeletal muscle tissue. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, which means it does not cause estrogen-mediated water retention or gynecomastia.

Proviron

DHT Derivative | Mood, Libido & Muscle Hardening

Proviron exerts its effects primarily through direct binding to the androgen receptor (AR) as a potent DHT analogue. However, its most therapeutically relevant mechanism is its exceptionally high binding affinity for sex hormone-binding globulin (SHBG).

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Oxandrolone with Proviron?

Combining Oxandrolone with Proviron is not recommended. Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Oxandrolone and Proviron safe together?

This combination carries significant risk. Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Oxandrolone and Proviron?

Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Oxandrolone and Proviron?

Oxandrolone has a half-life of ~9-10 hours and Proviron has a half-life of ~12 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

By increasing dopamine synthesis capacity, bromantane enhances baseline motivation, initiative, and the ability to engage in and sustain effortful tasks. Users consistently report improved ability to start and complete demanding cognitive work. Provides a clean, non-jittery mental energy that supports prolonged cognitive effort. Unlike stimulants that front-load neurotransmitter release and lead to a crash, bromantane's gene-expression-level mechanism delivers steady-state enhancement over the course of the day. The combination of dopaminergic upregulation and anxiolytic activity makes bromantane particularly useful for maintaining cognitive performance during periods of high psychological or physical stress. Approved in Russia for the treatment of asthenic disorders with anxiety. Clinical trials demonstrated significant reductions in anxiety scores without the sedation, cognitive dulling, or dependence potential of benzodiazepines. Primary approved indication in Russia. Bromantane addresses the fatigue, reduced drive, and emotional instability characteristic of asthenic conditions, restoring normal energy and emotional regulation. As an actoprotector, bromantane improves physical endurance and recovery under conditions of heat stress, sleep deprivation, and sustained exertion. Originally developed for military applications requiring sustained physical output in adverse environments. Some evidence suggests improved recovery from physical exertion, likely related to both the dopaminergic enhancement of central drive and the anxiolytic reduction of stress-mediated cortisol elevation.

Source: peptide-db.com ↗

Research Indications

VIP inhalation shows striking efficacy with increased mixed venous oxygen saturation and exercise capacity. Dilates peripheral blood vessels through NO-dependent mechanisms above 100 pmol doses. Coronary vasodilation with positive inotropic and chronotropic effects on the heart. Promising therapeutic target for Alzheimer's, Parkinson's, and other neurological disorders. Potential therapeutic target being researched for ASD. Produced in suprachiasmatic nuclei; involved in circadian regulation. Promotes insulin secretion in glucose-dependent manner via VPAC2; low hypoglycemia risk. Potent anti-inflammatory effects useful in IBD and autoimmune conditions. Therapeutic potential for pulmonary and systemic sarcoidosis.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Anastrozole is administered orally as a tablet. It is well absorbed with approximately 83-85% bioavailability, and absorption is not significantly affected by food. The long half-life of 40-50 hours supports dosing every other day or every three days for most estrogen management protocols, rather than daily dosing which is primarily reserved for the medical breast cancer indication. On-cycle estrogen management (conservative) 0.25mg Every other day (EOD) or every 3 days (E3D) Oral On-cycle estrogen management (moderate) 0.5mg On-cycle estrogen management (aggressive) 1mg Every other day (EOD) TRT adjunct (low-dose) 0.125-0.25mg Twice weekly or as needed based on bloodwork Breast cancer treatment (medical) Once daily

Source: peptide-db.com ↗
Side effects

What's the biggest side effect of ondansetron?

Constipation is the most common ongoing side effect because 5-HT3 blockade reduces gut motility. At 4-8 mg as-needed, this is usually mild and transient. With daily or frequent dosing, constipation becomes more pronounced and may require management with increased fiber, hydration, or occasional use of a stool softener or osmotic laxative.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides